Correlation Between Walker Dunlop and Xeris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Xeris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Xeris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Xeris Pharmaceuticals, you can compare the effects of market volatilities on Walker Dunlop and Xeris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Xeris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Xeris Pharmaceuticals.
Diversification Opportunities for Walker Dunlop and Xeris Pharmaceuticals
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Walker and Xeris is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Xeris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xeris Pharmaceuticals and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Xeris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xeris Pharmaceuticals has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Xeris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Walker Dunlop and Xeris Pharmaceuticals
Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 2.82 times less return on investment than Xeris Pharmaceuticals. But when comparing it to its historical volatility, Walker Dunlop is 2.0 times less risky than Xeris Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Xeris Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 149.00 in Xeris Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 160.00 from holding Xeris Pharmaceuticals or generate 107.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Walker Dunlop vs. Xeris Pharmaceuticals
Performance |
| Timeline |
| Walker Dunlop |
| Xeris Pharmaceuticals |
Walker Dunlop and Xeris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walker Dunlop and Xeris Pharmaceuticals
The main advantage of trading using opposite Walker Dunlop and Xeris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Xeris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xeris Pharmaceuticals will offset losses from the drop in Xeris Pharmaceuticals' long position.| Walker Dunlop vs. Mr Cooper Group | Walker Dunlop vs. Velocity Financial Llc | Walker Dunlop vs. Security National Financial | Walker Dunlop vs. Encore Capital Group |
| Xeris Pharmaceuticals vs. Capricor Therapeutics | Xeris Pharmaceuticals vs. Soleno Therapeutics | Xeris Pharmaceuticals vs. Bio Path Holdings | Xeris Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |